Physician profile
Devon Kneisel
NPI 1033977145
$856.41
in general payments reported to CMS, 2019-2025
21 companies · $546 in 2025
The $546 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $311 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.41 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $165.21 | 2025 | Tremfya, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.42 | 2025 | Xifaxan |
| Novo Nordisk INC | $97.82 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Dexcom, INC. | $46.11 | 2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $42.18 | 2025 | |
| Xeris Pharmaceuticals, INC. | $38.34 | 2024-2025 | Gvoke Hypopen |
| Acella Pharmaceuticals, LLC | $35.99 | 2024-2025 | NP Thyroid 60 |
| Sumitomo Pharma America, INC. | $35.89 | 2024 | Gemtesa |
| Takeda Pharmaceuticals U.S.A., INC. | $34.30 | 2025 | Entyvio |
| Antares Pharma, INC. | $28.45 | 2024-2025 | Xyosted |
| Biogen, INC. | $27.98 | 2024 | Skyclarys |
| Ibsa Pharma INC. | $24.90 | 2024 | Tirosint, Licart, Flector |
| Lundbeck LLC | $24.56 | 2024 | Vyepti |
| Lilly USA, LLC | $20.14 | 2025 | Zepbound, Mounjaro |
| Vivus LLC | $19.09 | 2025 | Pancreaze |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $18.61 | 2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $17.98 | 2024 | Airsupra |
| Ipsen Biopharmaceuticals, INC | $15.46 | 2025 | Iqirvo |
| Bayer Healthcare Pharmaceuticals INC. | $14.80 | 2024 | |
| Exact Sciences Corporation | $13.70 | 2024 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $13.48 | 2024 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Kneisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.